prostate cancer; adt; hypogonadism; testosterone

As part of the 2024 Prostate Cancer Patient Conference, Dr. Eric Small reviews Androgen Deprivation Therapy, including choices of agents, side effects, considerations in timing, duration, intensity of therapy, and discusses interpretation of clinical trial results.

https://www.onclive.com/view/trt-in-patients-with-prostate-cancer-on-active-surveillance-are-we-really-putting-gas-on-fire- Investigators hypothesized that testosterone replacement does not have a negative impact on the oncologic outcomes of treatment-naive patients with prostate cancer on...

https://music.amazon.ca/fr-ca/podcasts/3deef1ea-2731-48be-998b-7afc38ee8702/prostate-cancer-clinical-masterclass-series Welcome to The Prostate Cancer Clinical Masterclass Series which is co-chaired by Dr Sumit Subudhi and Dr Gerhardt Attard. This is a twelve-month initiative, consisting of...

Pituitary-testis axis dysfunction following adjuvant androgen deprivation therapy (2022) Julie Abildgaard, Hein Vincent Stroomberg, A Kirstine Bang, Jakob Albrethsen, Laura Smedegaard Kruuse, Anders Juul, Klaus Brasso, Andreas Røder, and Niels Jørgensen Abstract Men with high-risk...